D.E. Shaw & Co’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-45,100
Closed -$509K – 4557
2025
Q4
$509K Buy
+45,100
New +$559K ﹤0.01% 3923

Other funds holding BHVN

D.E. Shaw & Co's BHVN Position: Q3 2026 in Review

D.E. Shaw & Co reduced its Biohaven (BHVN) stake by 11% in Q3 2026, selling an estimated $6.72M and leaving 3,725,210 shares worth $49.7M. The position accounts for 0.02% of the portfolio, ranked #760.

D.E. Shaw & Co first reported a position in BHVN in Q4 2022 and has held it in 14 quarters since. The position peaked at $62.4M in Q2 2026. 304 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • D.E. Shaw & Co held 3,725,210 shares of Biohaven worth $49.7M as of Q3 2026.
  • D.E. Shaw & Co sold 464,985 Biohaven shares in Q3 2026, an estimated $6.72M.
  • Biohaven made up 0.02% of D.E. Shaw & Co's portfolio in Q3 2026, its #760 holding.
  • D.E. Shaw & Co first reported a position in Biohaven in Q4 2022 and has held it in 14 quarters since.
  • D.E. Shaw & Co's Biohaven position peaked at $62.4M in Q2 2026.
  • 304 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.